These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26090505)

  • 1. Autoantibodies Affect Brain Density Reduction in Nonneuropsychiatric Systemic Lupus Erythematosus Patients.
    Xu J; Cheng Y; Lai A; Lv Z; Campbell RA; Yu H; Luo C; Shan B; Xu L; Xu X
    J Immunol Res; 2015; 2015():920718. PubMed ID: 26090505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are serum autoantibodies associated with brain changes in systemic lupus erythematosus? MRI data from the Leiden NP-SLE cohort.
    Magro-Checa C; Kumar S; Ramiro S; Beaart-van de Voorde LJ; Eikenboom J; Ronen I; de Bresser J; van Buchem MA; Huizinga TW; Steup-Beekman GM
    Lupus; 2019 Jan; 28(1):94-103. PubMed ID: 30526327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced MRI techniques: biomarkers in neuropsychiatric lupus.
    Sarbu N; Toledano P; Calvo A; Roura E; Sarbu MI; Espinosa G; Lladó X; Cervera R; Bargalló N
    Lupus; 2017 Apr; 26(5):510-516. PubMed ID: 28394230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White-matter volume reduction and the protective effect of immunosuppressive therapy in systemic lupus erythematosus patients with normal appearance by conventional magnetic resonance imaging.
    Xu J; Cheng Y; Chai P; Lu Z; Li H; Luo C; Li X; Li L; Zhou Q; Chen B; Cao J; Xu X; Shan B; Xu L; Wen J
    J Rheumatol; 2010 May; 37(5):974-86. PubMed ID: 20231206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Migraine in patients with systemic lupus erythematosus is associated with reduced cerebral grey matter volume but not with measures of glial activation or anti-NR2 or anti-P antibodies.
    Tjensvoll AB; Lauvsnes MB; Hirohata S; Beyer MK; Greve OJ; Kvivik I; Kvaløy JT; Harboe E; Gøransson LG; Omdal R
    Eur J Neurol; 2016 Apr; 23(4):780-6. PubMed ID: 26787509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of hippocampal atrophy with cerebrospinal fluid antibodies against the NR2 subtype of the N-methyl-D-aspartate receptor in patients with systemic lupus erythematosus and patients with primary Sjögren's syndrome.
    Lauvsnes MB; Beyer MK; Kvaløy JT; Greve OJ; Appenzeller S; Kvivik I; Harboe E; Tjensvoll AB; Gøransson LG; Omdal R
    Arthritis Rheumatol; 2014 Dec; 66(12):3387-94. PubMed ID: 25156222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
    Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain unidentified bright objects ("UBO") in systemic lupus erythematosus: sometimes they come back. A study of microembolism by cMRI and Transcranial Doppler ultrasound.
    Bortoluzzi A; Padovan M; Azzini C; De Vito A; Trotta F; Govoni M
    Lupus; 2016 Feb; 25(2):193-8. PubMed ID: 26405021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo evaluation of brain damage in the course of systemic lupus erythematosus using magnetic resonance spectroscopy, perfusion-weighted and diffusion-tensor imaging.
    Zimny A; Szmyrka-Kaczmarek M; Szewczyk P; Bladowska J; Pokryszko-Dragan A; Gruszka E; Wiland P; Sasiadek M
    Lupus; 2014; 23(1):10-9. PubMed ID: 24192079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral magnetic resonance imaging in patients with or without antiphospholipid antibodies.
    Hachulla E; Michon-Pasturel U; Leys D; Pruvo JP; Queyrel V; Masy E; Arvieux J; Caron C; Brevet-Coupé F; Hatron PY; Devulder B
    Lupus; 1998; 7(2):124-31. PubMed ID: 9541097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multimodal MRI approach to identify and characterize microstructural brain changes in neuropsychiatric systemic lupus erythematosus.
    Ercan E; Ingo C; Tritanon O; Magro-Checa C; Smith A; Smith S; Huizinga T; van Buchem MA; Ronen I
    Neuroimage Clin; 2015; 8():337-44. PubMed ID: 26106559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance volumetry of pathological brain foci in patients with systemic lupus erythematosus.
    Podrazilová L; Peterová V; Olejárová M; Tegzová D; Krásenský J; Seidl Z; Kozelek P; Dostál C
    Clin Exp Rheumatol; 2008; 26(4):604-10. PubMed ID: 18799091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in White Matter Microstructure Suggest an Inflammatory Origin of Neuropsychiatric Systemic Lupus Erythematosus.
    Magro-Checa C; Ercan E; Wolterbeek R; Emmer B; van der Wee NJ; Middelkoop HA; Kruyt ND; Ronen I; van Buchem MA; Huizinga TW; Steup-Beekman GM
    Arthritis Rheumatol; 2016 Aug; 68(8):1945-54. PubMed ID: 26894522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippocampal Atrophy in Systemic Lupus Erythematosus Patients without Major Neuropsychiatric Manifestations.
    Liu S; Cheng Y; Zhao Y; Lai A; Lv Z; Xie Z; Upreti B; Wang X; Xu X; Luo C; Yu H; Shan B; Xu L; Xu J
    J Immunol Res; 2020; 2020():2943848. PubMed ID: 32626787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain MRI in neuropsychiatric lupus: associations with the 1999 ACR case definitions.
    Jeong HW; Her M; Bae JS; Kim SK; Lee SW; Kim HK; Kim D; Park N; Chung WT; Lee SY; Choe JY; Kim IJ
    Rheumatol Int; 2015 May; 35(5):861-9. PubMed ID: 25315702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
    Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J
    PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association among antioxidant enzymes, autoantibodies, and disease severity score in systemic lupus erythematosus: comparison of neuropsychiatric and nonneuropsychiatric groups.
    Su YJ; Cheng TT; Chen CJ; Chiu WC; Chang WN; Tsai NW; Kung CT; Lin WC; Huang CC; Chang YT; Su CM; Chiang YF; Cheng BC; Lu CH
    Biomed Res Int; 2014; 2014():137231. PubMed ID: 24877055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cluster analysis of autoantibodies in 852 patients with systemic lupus erythematosus from a single center.
    Artim-Esen B; Çene E; Şahinkaya Y; Ertan S; Pehlivan Ö; Kamali S; Gül A; Öcal L; Aral O; Inanç M
    J Rheumatol; 2014 Jul; 41(7):1304-10. PubMed ID: 24833757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of central nervous system damage in patients with neuropsychiatric systemic lupus erythematosus, demonstrated by magnetization transfer imaging.
    Bosma GP; Rood MJ; Zwinderman AH; Huizinga TW; van Buchem MA
    Arthritis Rheum; 2000 Jan; 43(1):48-54. PubMed ID: 10643699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional brain connectomes in patients with systemic lupus erythematosus.
    Preziosa P; Rocca MA; Ramirez GA; Bozzolo EP; Canti V; Pagani E; Valsasina P; Moiola L; Rovere-Querini P; Manfredi AA; Filippi M
    Eur J Neurol; 2020 Jan; 27(1):113-e2. PubMed ID: 31306535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.